27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Vitro Biopharma, Inc (NASDAQ:VTRO) IPO will take place August, 09 on the NASDAQ exchange under the ticker VTRO.
The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on February 05, 2024.
See also: Benzinga IPO Calendar
About Vitro Biopharma, Inc
Vitro Biopharma, Inc is an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. With respect to our regenerative medicine business
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!